EUVIMEDOpdag EUVIMED
MetaanalyseSystematische ÜbersichtOpen access · CC BY-NC-ND 4.0

Gut microbiota changes in patients with hypertension: A systematic review and meta‐analysis

Meiling Cai, Lingyu Lin, Fei Jiang, Yanchun Peng, Sailan Li, Liangwan Chen, Yanjuan Lin iD

The Journal of Clinical Hypertension · 2023-12 · 25 (12) · 1053-1068

DOI: 10.1111/jch.14722 ↗

At a glance

Metaanalyse in The Journal of Clinical Hypertension, published online on 2023-10-18. Written by Meiling Cai and 6 co-authors. Institution: Department of Nursing, Fujian Medical University Union Hospital, Fuzhou, China. Major MEDLINE topics: Hypertension, Gastrointestinal Microbiome. Cited 53 times so far (Crossref); 61 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: The Medical Innovation Project of Fujian Provincial Health Commission, Guiding Project of Fujian Science and Technology, Fujian Provincial Special Reserve Talents Laboratory (Fujian Medical University Union Hospital).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Hypertension is a major public health issue worldwide. The imbalance of gut microbiota is thought to play an important role in the pathogenesis of hypertension. The authors conducted the systematic review and meta‐analysis to clarify the relationship between gut microbiota and hypertension through conducting an electronic search in six databases. Our meta‐analysis included 19 studies and the results showed that compared with healthy controls, Shannon significantly decreased in hypertension [ SMD = −0.13, 95% CI (−0.22, −0.04), p = .007]; however, Simpson [ SMD = −0.01, 95% CI (−0.14, 0.12), p = .87], ACE [ SMD = 0.18, 95% CI (−0.06, 0.43), p = .14], and Chao1 [ SMD = 0.11, 95% CI (−0.01, 0.23), p = .08] did not differ significantly between hypertension and healthy controls. The F/B ratio significantly increased in hypertension [ SMD = 0.84, 95% CI (0.10, 1.58), p = .03]. In addition, Shannon index was negatively correlated with hypertension [ r = −0.12, 95% CI (−0.19, −0.05)], but had no significant correlation with SBP [ r = 0.10, 95% CI (−0.19, 0.37)] and DBP [ r = −0.39, 95% CI (−0.73, 0.12)]. At the phylum level, the relative abundance of Firmicutes [ SMD = −0.01, 95% CI (−0.37, 0.34), p = .94], Bacteroidetes [ SMD = −0.15, 95% CI (−0.44, 0.14), p = .30], Proteobacteria [ SMD = 0.25, 95% CI (−0.01, 0.51), p = .06], and Actinobacteria [ SMD = 0.21, 95% CI (−0.11, 0.53), p = .21] did not differ significantly between hypertension and healthy controls. At the genus level, compared with healthy controls, the relative abundance of Faecalibacterium decreased significantly [ SMD = −0.16, 95% CI (−0.28, −0.04), p = .01], while the Streptococcus [ SMD = 0.20, 95% CI (0.08, 0.32), p = .001] and Enterococcus [ SMD = 0.20, 95% CI (0.08, 0.33), p = .002] significantly increased in hypertension. Available evidence suggests that hypertensive patients may have an imbalance of gut microbiota. However, it still needs further validation by large sample size studies of high quality.

Subjects

MeSH terms (MEDLINE)

HypertensionGastrointestinal MicrobiomeHumans

Author keywords

gut microbiotahigh throughput sequencinghypertensionmeta-analysissystematic review

Authors and institutions

  • Department of Nursing, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Fujian Provincial Special Reserve Talents Laboratory, Fujian Medical University Union Hospital, Fuzhou, China.

ORCID profiles: Yanjuan Lin

Funding

  • The Medical Innovation Project of Fujian Provincial Health Commission
  • Guiding Project of Fujian Science and Technology
  • Fujian Provincial Special Reserve Talents Laboratory (Fujian Medical University Union Hospital)
  • Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University)
  • Fujian Province University

Cite

APA

Cai, M., Lin, L., Jiang, F., Peng, Y., Li, S., Chen, L., & Lin, Y. (2023). Gut microbiota changes in patients with hypertension: A systematic review and meta‐analysis. The Journal of Clinical Hypertension, 25(12), 1053-1068. https://doi.org/10.1111/jch.14722

Vancouver

Cai M, Lin L, Jiang F, Peng Y, Li S, Chen L, et al. Gut microbiota changes in patients with hypertension: A systematic review and meta‐analysis. The Journal of Clinical Hypertension. 2023;25(12):1053-1068. doi:10.1111/jch.14722

BibTeX
@article{Cai2023,
  author = {Cai, Meiling and Lin, Lingyu and Jiang, Fei and Peng, Yanchun and Li, Sailan and Chen, Liangwan and Lin, Yanjuan},
  title = {Gut microbiota changes in patients with hypertension: A systematic review and meta‐analysis},
  journal = {The Journal of Clinical Hypertension},
  year = {2023},
  volume = {25},
  number = {12},
  pages = {1053--1068},
  doi = {10.1111/jch.14722}
}
Start for free →